V Kumar, B Prasad, S Singh - Drug Discovery Today: Therapeutic Strategies, 2008 - Elsevier Cardiovascular diseases (CVDs) are the foremost cause of mortality worldwide. It
is estimated that around 20 million people will die from CVDs by 2015.
Accordingly, there is a need to develop treatment strategies, which on ... Cited by 2 - Related articles
JB Marks - Clinical Diabetes, 2006 - Am Diabetes Assoc As pointed out in this issue's commentary by KM Venkat Narayan, MD, MPH, FRCP,
FACP (p. 38), the association of several cardiovascular disease (CVD) risk
factors—central obesity, hypertension, dys-lipidemia, and abnormalities ... Cited by 1 - Related articles - BL Direct - All 2 versions
V Kumar, RP Shah, S Singh - Journal of Pharmaceutical and Biomedical Analysis, 2008 - Elsevier “Polypill” is a fixed-dose combination (FDC) containing three or more drugs
in a single pill. The same is under development for the treatment and prevention
of cardiovascular diseases. In the present study, gradient LC methods were ... Related articles - All 3 versions